Immunological characteristics of diabetes in schizophrenia [1]

Diabetologia

Volumn 48, Issue 9, 2005, Pages 1941-1942

  Cohen, Dan ^a   Batstra, M R ^b   Gispen De Wied, C C ^c  

^a Geestelijke GezondheidsZorg ^*  (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTAMATE DECARBOXYLASE;

AUTOIMMUNITY; BLOOD SAMPLING; CLINICAL FEATURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GLUCOSE METABOLISM; HUMAN; INFORMED CONSENT; LETTER; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RADIOIMMUNOASSAY; SAMPLE SIZE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; AUTOANTIBODIES; CHLORPROMAZINE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; INSULIN ANTIBODIES; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 24944589598     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1879-z     Document Type: Letter

References (14)

1. Maudsley H (1899) The pathology of mind. 3rd edn. Appleton, New York
2. Cohen D (2004) Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature. Pharmacopsychiatry 37:1-11
3. Lindenmayer JP, Czobor P, Volavka J et al (2003) Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 166:290-296
4. Koller E, Schneider B, Bennett K, Dubitsky G (2001) Clozapine-associated diabetes. Am J Med 111:716-723
5. Koller EA, Doraiswamy PM (2002) Olanzapine-associated diabetes mellitus. Pharmacotherapy 77:841-852
6. Koller EA, Weber J, Doraiswamy PM, Schneider BS (2004) A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. J Clin Psychiatry 65:857-863
7. Batstra MR, van Driel A, Petersen JS et al (1999) Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values. Clin Chem 45:2269-2272
8. Batstra MR, Petersen JS, Bruining GJ (2001) Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of the Netherlands. Hum Immunol 62:1106-1110
9. Greenbaum CJ, Wilkin TJ, Palmer JP (1992) Fifth International Serum Exchange Workshop for Insulin Autoantibody (LAA) Standardization. The Immunology and Diabetes Workshops and participating laboratories. Diabetologia 35:798-800
10. Baan CA, Feskens EJM (2001) Disease burden of diabetes mellitus type II in the Netherlands: incidence, prevalence and mortality [Article in Dutch]. Ned Tijdschr Geneeskd 145:1681-1685
11. Ruige JB, Batstra MR, Aanstoot HJ et al (1997) Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population. The Hoorn Study. Diabetes Care 20:1108-1110
12. Pietropaolo M, Barinas-Mitchell E, Pietropaolo SL, Kuller LH, Trucco M (2000) Evidence of islet cell auto immunity in elderly patients with type 2 diabetes. Annual Rev Diabetes 49:32-38
13. Subramaniam M, Chong SA, Pek E (2003) Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia. Can J Psychiatry 48:345-347
14. Finney GOH (1989) Juvenile onset diabetes and schizophrenia? Lancet 1214-1215